We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0RA9 market cap is 156.19M. The company's latest EPS is EUR -2.7222 and P/E is -4.92.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 815k | 23k | 6.75M | 11.96M | 4.58M |
Operating Income | -19.11M | -33.3M | -33.17M | -41.4M | -64.84M |
Net Income | -15.82M | -30.63M | -37.63M | -42.45M | -60.74M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 54.05M | 51.73M | 69.71M | 109.23M | 75.54M |
Total Liabilities | 25.3M | 39.95M | 67.98M | 83.3M | 68.36M |
Total Equity | 28.74M | 11.78M | 1.73M | 25.93M | 7.19M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -14.6M | -27.47M | -27.99M | -45.05M | -53.94M |
Investing | -255k | -370k | -513k | -6.23M | -12.03M |
Financing | 10.83M | 24.61M | 48.03M | 82.68M | 32.21M |
Market Cap | 156.19M |
Price to Earnings Ratio | -4.92 |
Price to Sales Ratio | 65.24 |
Price to Cash Ratio | 11.09 |
Price to Book Ratio | 41.59 |
Dividend Yield | - |
Shares Outstanding | 22.31M |
Average Volume (1 week) | 744 |
Average Volume (1 Month) | 1.49k |
52 Week Change | 0.00% |
52 Week High | 7.00 |
52 Week Low | 7.00 |
Spread (Intraday) | 0 (0%) |
Company Name | Abivax Sa |
Address |
7-11 boulevard haussmann paris, paris 75009 |
Website | https://www.abivax.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions